To the best of our knowledge, our study was the first time to suggest that ITGβ3 overexpression increased the damage to the podocytes by regulating the RhoA–YAP pathway, which provides novel clue for DN treatment. This evidence concerns the gene YAP1 and liver dysplastic nodule.